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INTRODUCTION
A clinical trial is a research study that
prospectively assigns health-related inter-
ventions to people (or groups) typically
using randomisation to evaluate the
effects on health outcomes. Well-
designed, suitably powered, randomised,
trials provide the most reliable evidence
about the effectiveness (or not) of inter-
ventions and should underpin medical
practice. Unfortunately, within paediat-
rics, many common interventions have
not been subjected to such rigorous
evaluation,1 2 leading to variation in both
treatments3 4 and outcomes (http://www.
rightcare.nhs.uk/index.php/atlas/children-
and-young-adults/).
Many more high-quality clinical trials
are needed before paediatric care is
robustly evidence based. Healthcare pro-
fessionals are ideally placed to inform
such trials, but one factor that limits their
involvement is the complexity involved:
the processes and requirements for trials
of investigational medicinal products are
illustrated on the clinical trials route map
(http://www.ct-toolkit.ac.uk/routemap).
There has been a significant investment
in clinical trials research infrastructure
over the last decade recognising this com-
plexity. The UK Clinical Research
Collaboration Registered Clinical Trials
Units (CTU) Network is part of this infra-
structure and oversees the registration of
CTUs. Registered CTUs need to demon-
strate track record, a multidisciplinary
team, robust quality assurance systems,
statistical input and secure information
technology. CTUs exist to help healthcare
professionals navigate this complex land-
scape and assist in developing clinical
questions into well-designed studies.
The history of CTUs
The first UK unit to undertake clinical
trials was the Tuberculosis Research Unit
in 1948. Further specialist trials units
were established in subsequent decades,
followed by a more general expansion
over the last 20 years. In 2003, a registra-
tion process was introduced by the UK
Clinical Research Collaboration (UKCRC)
to help improve the quality and quantity
of UK clinical trials expertise. There are
currently 51 registered UK CTUs (http://
www.ukcrc-ctu.org.uk/?page=Results)
(figure 1), and the National Institute of
Health Research (NIHR) provides add-
itional funding to 25 of these to specific-
ally support NIHR projects (http://www.
nets.nihr.ac.uk/resources/nihr-ctu).
The role of a CTU
CTUs have the expertise to provide statis-
tical, epidemiological, logistical and
methodological advice, and the coordin-
ation to successfully undertake multicen-
tre clinical trials, nationally and
internationally. Most CTUs will be able to
coordinate clinical trials of investigational
medical products in compliance with UK
Regulations—specifically, CTUs have the
expertise and infrastructure to produce
the regulatory compliant documents,
databases and monitoring plans required
for such trials. CTUs commonly specialise
in the trials that they adopt, either by
medical specialty (eg, the National
Perinatal Epidemiology Unit CTU and
perinatal trials) or methodology (eg, the
Pragmatic CTU and cluster randomised
trials). While there are no dedicated
paediatric units, many CTUs support
paediatric studies that fall within their
area of specialisation. UKCRC CTUs can
be searched by disease, methodology or
study type at http://www.ukcrc-ctu.org.
uk/search/custom.asp?id=468.
CTUs ideally work with a chief investi-
gator from the outset, helping to develop
the right research question, setting and
methodologically rigorous design. If a
trial is successfully funded, the CTU will
then usually see it through completion to
dissemination. Common services and
functions provided by a CTU are sum-
marised in figure 2.
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Working with a CTU
So what are the next steps once you have identified an
important research question suitable for a clinical
trial? The first step is to formulate the question into
Participant, Intervention, Comparator, Outcome
format before ensuring that it has not already been
answered by checking for recent systematic reviews or
performing a literature/systematic review. The NIHR
Research Design Service (RDS, http://www.rds.nihr.ac.
uk/) can provide assistance where research is likely to
fall within remit. A trial is more likely to be funded if
it addresses a topic identified as a research priority:
priority setting partnerships have been established by
the James Lind Alliance (http://www.jla.nihr.ac.uk/) in
many specialties like preterm birth.5 At this stage, it is
important to identify potential funding streams; CTUs
can assist with this process, although for clinical
studies, funding often entails NIHR streams.
Meaningful patient and public involvement is essential
for NIHR-funded trials and should be included as
early as possible; INVOLVE (http://www.invo.org.uk/)
and the RDS can provide guidance here.
Approaching a CTU for support will usually involve
an application form or ‘collaboration request’. While
it is essential that this process starts at least 3 months
before any target funding deadline, the strongest
Figure 1 Map of the UK Clinical Research Collaboration
(UKCRC), registered clinical trials units (CTUs).
Figure 2 Services and functions of a clinical trials unit (CTU). CRN, Clinical Research Network; MHRA, Medicines and Healthcare
Products Regulatory Agency; NHS, National Health Service; NIHR, National Institute of Health Research; R&D, research and
development.
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collaborations and proposals often result from an
iterative process involving multiple stakeholders
including CTUs, public/patient representatives and
National Health Service sites, which may often take
considerably longer. Any clinical trial needs to eventu-
ally (directly or indirectly) lead to tangible patient or
health service benefits in order to have a realistic
chance of being funded; the application or ‘collabor-
ation’ stage is the CTU’s way of determining whether
a proposed trial is within remit and is likely to
succeed. This is a competitive process, where demon-
strating feasibility and eventual patient benefit is key.
Any collaboration request will be reviewed within the
CTU to judge whether it is competitive and should be
supported. If a proposed trial is supported, the
resources of the CTU will then work in partnership
with the chief investigator to build a strong team to
design and deliver the trial, developing the methodo-
logical, statistical, organisational and regulatory com-
ponents in preparation for the next major hurdle,
grant submission.
Many funders (including the NIHR) expect clinical
trials to be run through a UKCRC registered CTU or
require a justification for not doing so; the CTU costs,
which incorporate statistical support, trial manage-
ment, quality control, audit, database management
and many other functions, will be included in any
grant application. A CTU will also support the
complex cost calculations for clinical research using
the Attributing the Costs of Health and Social Care
Research and Development (AcoRD) framework.
SUMMARY
Clinical trials are essential to improving paediatric and
neonatal care, and paediatricians in tandem with
parent and user groups are ideally placed to identify
the key questions to be examined in such trials. A
CTU can provide expert advice and support in
tandem with healthcare professionals to develop a
clinical trial; the most fruitful collaborations evolve
from early consultation.
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